Filing Details
- Accession Number:
- 0001181431-11-028492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-10 13:53:35
- Reporting Period:
- 2011-05-06
- Filing Date:
- 2011-05-10
- Accepted Time:
- 2011-05-10 13:53:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1321178 | Moshe Arkin | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-05-06 | 59,795 | $87.06 | 5,796,379 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Common Stock | Disposition | 2011-05-06 | 5,300 | $87.79 | 5,791,079 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Common Stock | Disposition | 2011-05-09 | 141,127 | $87.63 | 5,649,952 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,130 | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $86.70 to $87.70. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $87.71 to $87.89. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $87.50 to $88.33. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range